Exodus Point Capital Management, LP Adagio Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 63,453 shares of ADGI stock, worth $210,029. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,453Holding current value
$210,029% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADGI
# of Institutions
94Shares Held
64MCall Options Held
828KPut Options Held
23.4K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx11.8MShares$38.9 Million0.77% of portfolio
-
Deep Track Capital, LP Greenwich, CT11MShares$36.3 Million1.2% of portfolio
-
M28 Capital Management LP Stamford, CT9.25MShares$30.6 Million28.73% of portfolio
-
Alphabet Inc. Mountain View, CA4.53MShares$15 Million0.66% of portfolio
-
Slate Path Capital LP New York, NY3.74MShares$12.4 Million0.25% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...